Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ).
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has scheduled a board meeting for March 30, 2026 to review and approve the annual results for the financial year ended December 31, 2025. The board will also consider the proposal of a final dividend, signaling a potential distribution to shareholders and offering an early indication of the company’s financial performance and capital return policy.
The announcement confirms the current composition of the board, led by Chairman and executive director Chen Juan alongside non-executive and independent non-executive directors. This reinforces the company’s governance structure as it approaches its results season, a key moment for investors monitoring profitability, cash generation, and any prospective dividend payout.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a Mainland China-incorporated joint stock company listed in Hong Kong and engaged in the medical technology sector. The company operates through subsidiaries to provide medical devices and related technologies, targeting healthcare markets in China and potentially broader international medical markets.
Average Trading Volume: 235,231
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.27B
Learn more about 2291 stock on TipRanks’ Stock Analysis page.